Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2012; 18(36): 4994-5013
Published online Sep 28, 2012. doi: 10.3748/wjg.v18.i36.4994
Published online Sep 28, 2012. doi: 10.3748/wjg.v18.i36.4994
Type of medication | Drugs |
Laxatives | |
Bulking (insoluble and soluble fibres) | Bran, methylcellulose, psyllium |
Osmotic | Lactulose, sorbitol, magnesium hydroxide, magnesium salts, polyethylene glycol |
Stimulant | Anthraquinone derivatives: senna, aloe, cascara |
Diphenylmethane derivatives: bisacodyl, sodium picosulfate | |
Softening | Liquid paraffin (vaseline oil), docusate, glycerine |
Serotoninergic enterokinetic agents | Tegaserod, prucalopride, renzapride |
Prosecretory agents | Lubiprostone, linaclotide |
Gastrointestinal μ-opioid antagonists | Methylnaltrexone, alvimopan |
Probiotics | Bifidobacterium, lactobacillus |
Colchicine |
- Citation: Bove A, Bellini M, Battaglia E, Bocchini R, Gambaccini D, Bove V, Pucciani F, Altomare DF, Dodi G, Sciaudone G, Falletto E, Piloni V. Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (Part II: Treatment). World J Gastroenterol 2012; 18(36): 4994-5013
- URL: https://www.wjgnet.com/1007-9327/full/v18/i36/4994.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i36.4994